Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Astera Labs Inc (NASDAQ: ALAB) was $143.66 for the day, down -3.49% from the previous closing price of $148.85. In other words, the price has decreased by -$3.49 from its previous closing price. On the day, 5.27 million shares were traded. ALAB stock price reached its highest trading level at $152.19 during the session, while it also had its lowest trading level at $143.08.
Ratios:
Our analysis of ALAB’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 105.76. For the most recent quarter (mrq), Quick Ratio is recorded 12.27 and its Current Ratio is at 12.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 01 ’25 when ALBA MANUEL sold 33,000 shares for $166.18 per share. The transaction valued at 5,483,981 led to the insider holds 352,863 shares of the business.
ALBA MANUEL sold 150,000 shares of ALAB for $24,927,221 on Dec 01 ’25. The Director now owns 1,574,498 shares after completing the transaction at $166.18 per share. On Dec 01 ’25, another insider, MAR 2011 CHILDRENS TRUST U/A D, who serves as the Director of the company, bought 170,000 shares for $157.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 24264693760 and an Enterprise Value of 23161585664. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 127.90, and their Forward P/E ratio for the next fiscal year is 59.58. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 33.56 while its Price-to-Book (P/B) ratio in mrq is 19.08. Its current Enterprise Value per Revenue stands at 32.034 whereas that against EBITDA is 207.604.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.60, which has changed by 0.16343594 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is -13.67%, while the 200-Day Moving Average is calculated to be 11.52%.
Shares Statistics:
ALAB traded an average of 6.56M shares per day over the past three months and 7325230 shares per day over the past ten days. A total of 168.90M shares are outstanding, with a floating share count of 134.35M. Insiders hold about 20.46% of the company’s shares, while institutions hold 66.30% stake in the company. Shares short for ALAB as of 1764288000 were 12081579 with a Short Ratio of 1.84, compared to 1761868800 on 8398986. Therefore, it implies a Short% of Shares Outstanding of 12081579 and a Short% of Float of 9.67.
Earnings Estimates
Astera Labs Inc (ALAB) is presently subject to a detailed evaluation by 19.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.52, with high estimates of $0.56 and low estimates of $0.47.
Analysts are recommending an EPS of between $1.8 and $1.76 for the fiscal current year, implying an average EPS of $1.78. EPS for the following year is $2.37, with 19.0 analysts recommending between $2.81 and $2.0.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 17 analysts. It ranges from a high estimate of $251.3M to a low estimate of $248.9M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $141.1MFor the next quarter, 17 analysts are estimating revenue of $258.71M. There is a high estimate of $266.45M for the next quarter, whereas the lowest estimate is $249.1M.
A total of 21 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $833.3M, while the lowest revenue estimate was $774.54M, resulting in an average revenue estimate of $827.5M. In the same quarter a year ago, actual revenue was $396.29MBased on 19 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.33B and the low estimate is $1.07B.
